RenoVo

Supplied By: Equine Amnio Solutions LLC (RV-010300)


SKU
074092


Unit of
Measure
3cc


Pack
Type
Vial


Case
Qty
1

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Dec- 2024 Nov- 2024 Oct- 2024 Sep- 2024 Aug- 2024 Jul- 2024 Jun- 2024 May- 2024 Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023
{{purchaseHistoryItem}}


SKU
074092


Size
3cc

Case
Qty
1

Purchase History

Dec- 2024 {{productPurchaseHistory['074092'][0]}} May- 2024 {{productPurchaseHistory['074092'][0+7]}}
Nov- 2024 {{productPurchaseHistory['074092'][1]}} Apr- 2024 {{productPurchaseHistory['074092'][1+7]}}
Oct- 2024 {{productPurchaseHistory['074092'][2]}} Mar- 2024 {{productPurchaseHistory['074092'][2+7]}}
Sep- 2024 {{productPurchaseHistory['074092'][3]}} Feb- 2024 {{productPurchaseHistory['074092'][3+7]}}
Aug- 2024 {{productPurchaseHistory['074092'][4]}} Jan- 2024 {{productPurchaseHistory['074092'][4+7]}}
Jul- 2024 {{productPurchaseHistory['074092'][5]}} Dec- 2023 {{productPurchaseHistory['074092'][5+7]}}
Jun- 2024 {{productPurchaseHistory['074092'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

RenoVo® is a liquid allograft comprised of equine amnion and amniotic fluid. It is provided cryopreserved in a single use vial. RenoVo® is intended to supplement and protect tissues. RenoVo® is intended for implantation in one animal. Unused allograft must not be refrigerated or refrozen. Only qualified veterinary professionals should implant RenoVo®. This product is processed aseptically. Do not sterilize.

Features & Benefits

  • Amnion and amniotic fluid are rich sources of biologically active factors involved in tissue regeneration with reported anti-inflammatory, anti-bacterial, re-epithelialization, and anti-fibrotic properties
  • RenoVo® is enjoying rapid adoption as a superior alternative to autologous and other therapies
  • Ready availability of an allograft potentiates clinical use without having time lapse for culturing cells or harvest techniques required for PRP and other autologous therapies due to individual variability within products such as PRP, cytokine and growth factor profiles can vary dramatically between patients
  • The reproducibility of each donor tissue also offers a more homogeneous protein concentration and product consistency in comparison to other regenerative modalities
  • RenoVo® is cryopreserved and maintained frozen before use, to preserve beneficial proteins that may not survive lyophilization